Pacific Edge shares more than double on US healthcare news

Pacific Edge shares more than double on US healthcare news
Brent Melville
Pacific Edge shares more than doubled in value on confirmation of acceptance under a key US medical regulation for its Cxbladder cancer test. The shares jumped as high as 68 cents from 27 cents yesterday, and were recently at 55 cents, up 104 percent and valuing the company at $379.3 million. The successful standard of care rating from the US Centres for Medicare and Medicaid Services means Pacific Edge will be reimbursed at a rate of US$760 per test from July 1, 2020.  The CMS provides healthcare coverage for all US citizens over the...

More Services

Latest cap raise values Sharesies at $750m
Markets

Latest cap raise values Sharesies at $750m

In its eighth raise since 2017, Sharesies values its shares at $205 apiece.

Pattrick Smellie 10 Oct 2025
Two MC partners quit for specialist firm
Services

Two MC partners quit for specialist firm

Cuncannon now has a broader commercial offering. 

Staff reporters 06 Oct 2025
DB Breweries appoints new MD
Retail

DB Breweries appoints new MD

Peter Hart returns to NZ.

Victoria Young 01 Oct 2025
2degrees earnings show cash momentum
Services

2degrees earnings show cash momentum

Non-cash costs mask strong operating earnings and cashflow.

Pattrick Smellie 24 Sep 2025